Ultrasound contrast agent delivered per OS first diagnoses pharyngoesophageal tumour

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Oral administration of ultrasound contrast agents has been described very little so far in medical literature. These agents are mainly administered intravenously and, less commonly, intracavitarily. We present the case of a patient with a cervical mass in whom sonographic examination with per os administration of SonoVue led to the diagnosis of a pharyngoesophageal tumour. The diagnosis was confirmed on barium swallow and endoscopy-guided biopsy.

Author supplied keywords

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Antypa, E., Cokkinos, D. D., Kalogeropoulos, I., Tomais, D., & Piperopoulos, P. N. (2013). Ultrasound contrast agent delivered per OS first diagnoses pharyngoesophageal tumour. JBR-BTR, 96(2), 69–71. https://doi.org/10.5334/jbr-btr.211

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Professor / Associate Prof. 2

33%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

71%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Veterinary Science and Veterinary Medic... 1

14%

Save time finding and organizing research with Mendeley

Sign up for free